Replies to post #54952 on Bioelectronics Corp (BIEL)

[seven-up]

Are You Ready-BUY-BIEL-DO-NOT-BELIEVE-POST-WITH-INCORRECT-INFORMATION
The saying goes "No Pain, No Gain" and last night we brought a FULL REPORT on a company working to actually generate significant gains from managing pain! We also noted a VERY INTERESTING Sub-Penny Bottom Bounce chart set-up that could ALSO be in the works heading into this morning:

BioElectronics Corporation (BIEL)
Today we've got this in our sights. Not only has the company been growing this year as you'll see below but the chart on this one could have all the tell tale signs of repeat breakout contender! BIEL has not only shown a history of bottom bounce breakouts from EXACTLY Wednesday's closing price point BUT it has also managed to uphold a near 6 month support level EVEN AFTER seeing heavy downward pressure. This indicates to us that there could be a true reversal brewing...
What's more is that BIEL isn't chart a pretty face in the chart world. The company is a leader in Bioelectroceutical devices and the maker of an industry leading family of disposable, drug-free, anti-inflammatory devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy for veterinary applications, Allay® Menstrual Pain Therapy and Smart Insole™ Heel Pain Therapy. To see what the company just accomplished via a new study, read last night's FULL REPORT.
BIEL has made it its duty to deal with pain. According to the Pain Management Therapeutics Market Research report from Transparency Market Research, the global pain management devices market was estimated at US$2.0 billion in 2011 and, growing at a CAGR of 13.1%, is predicted to reach US$5.0 billion by 2018.
With such recent success during its second quarter as well as the inclusion in the 9th Congress of the European Pain Federation, BIEL could be on pace for a strong year. Heading into Thursday we feel that with these highlights and the current chart set-up, BIEL could start to hit many more scanners for a potential bottom bounce breakout heading into the open!

[edbi46]

<<< ATTENTION INVESTORS >>> DON'T LISTEN TO ANYONE !!!! DO YOUR OWN DD !!! Go to BIOELECTRONICS website,learn about the products, read the financials ( don't forget, that this is not an IBM or a MICROSOFT, this is a MICROCAP company, that is trying to gain FDA OTC permission and WORLDWIDE market of $10 billion ), calculate the RISKS involved / RETURN possibilities ratio ( just like in any other PINKSHEET ) and only then make your decision to buy !!!!!! REMEMBER to invest only as much, as you could afford to lose ( in the worst case scenario ) GLTYA.!!

[edbi46]

OUCH!!! WATCH THAT LOCOMOTIVE, named BIEL, approaching at full speed !!!! Theres many things are happening now!!!........................... -The final order for Reclassification and Renaming of Shortwave Diathermy for All Other Uses is over due and could be published at any time.
- A new 510k was filed for the ActiPatch on 8/6/2015. The FDA suggested this course of action while waiting on the final order. BIEL was advised on this filing by the law firm of Goodwin Procter, whose lead FDA attorney Mark Heller has 10 years experience working with the FDA's Device Division. The FDA has a commitment to process 510ks within a 90 day period.
- As of 6/30/2015 BIEL had sales of $1,178,796 for fiscal 2015. This is a $732,516 increase over the same period in 2014.
- There are 585 Boots Pharmacy Stores selling BIEL products in the UK.
- B. Braun, a 175 year old company that sells $6 billion a year in medical products, signed on as the exclusive UK distributor for Recoveryrx after clinical evaluation.
- In his 8/2014 interview BIEL EVP Dr. Kotak said " I joined Bioelectroincs in March (2014) with a roll to drive the European and Rest of World roll out of the current product line as well as bring on the development of the deep and diverse pipeline that Bioelectronics has." " We are the leaders in non invasive electrocuticals and we have new devices for chronic pain that are more powerful and we are going to be entering the field of Neuromodulation. Wherever there is nerve that is accessible to our technology we can stimulate it, and that gives us access to some very large markets."
- Neuromodulation is technology that acts directly upon nerves. It is the alteration—or modulation—of nerve activity by delivering electrical or pharmaceutical agents directly to a target area.Neuromodulation devices and treatments are life changing.
-In his 8/2015 interview AW said " We have 5 on going clinical trials that we are doing for new products. We clearly see that we can solve and use the product for things like Migraine Headaches, Diabetic Neuropathy, and Post Operative Chronic Wounds....

[suofin]

Not a paid promo this was posted in the Federal Register which is produced by the Federal Printing office. You can get it by logging into the federal register. EE Communications would not be stupid enough to put out a fake federal document. LOL